CompletedNot Applicable

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes

United States112 participantsStarted 2016-05

Plain-language summary

This is a randomized prospective clinical study in patients with type 2 diabetes to evaluate the effect of dairy products with full or low fat on glycemic control and cardio-metabolic risk factors in comparison to a regular diet.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Having type 2 diabetes for at least three months prior to screening and treated with any antihyperglycemic medication * A1C ≥7 % * Consuming \<3 servings of dairy products per day * On stable dose of diabetes, blood pressure or cholesterol medications for 3 months * Body weight is within 10% of current weight over the last 6 months before starting the study Exclusion Criteria: * Pregnancy or lactation * Lactose intolerance * Allergy to milk or any of its components * Use of orlistat * History of pancreatitis * History of gastric bypass surgery or sleeve gastrectomy * Active malignancy * History of recent cardiovascular event * Having a heart pacemaker * Enrollment in other studies that may affect study outcomes

What they're measuring

Change in Hemoglobin A1C (A1C)

Timeframe: Baseline, 12 weeks and 24 weeks

Trial details

NCT IDNCT02895867

SponsorJoslin Diabetes Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-07

View on ClinicalTrials.gov More Type 2 Diabetes trials